Norbert Dereu

1.4k total citations
37 papers, 1.0k citations indexed

About

Norbert Dereu is a scholar working on Toxicology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Norbert Dereu has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Toxicology, 20 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Norbert Dereu's work include Organoselenium and organotellurium chemistry (22 papers), Free Radicals and Antioxidants (9 papers) and Organic Chemistry Cycloaddition Reactions (6 papers). Norbert Dereu is often cited by papers focused on Organoselenium and organotellurium chemistry (22 papers), Free Radicals and Antioxidants (9 papers) and Organic Chemistry Cycloaddition Reactions (6 papers). Norbert Dereu collaborates with scholars based in France, Belgium and United States. Norbert Dereu's co-authors include Hartmut Fischer, M. Renson, Anne Bousseau, Yvette Hénin, Michel Evers, Rudi Pauwels, Erik De Clercq, Christèle Poujade, Thierry Huet and Jean‐Bernard Le Pecq and has published in prestigious journals such as Proceedings of the National Academy of Sciences, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Norbert Dereu

37 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Dereu France 17 439 425 380 149 100 37 1.0k
Michel Evers Belgium 11 211 0.5× 132 0.3× 228 0.6× 33 0.2× 62 0.6× 16 471
Stanislas Czernecki France 24 1.4k 3.2× 51 0.1× 892 2.3× 46 0.3× 102 1.0× 85 1.7k
В. Е. Катаев Russia 20 604 1.4× 79 0.2× 631 1.7× 401 2.7× 60 0.6× 140 1.3k
William A. Greenberg United States 22 937 2.1× 55 0.1× 1.5k 4.0× 25 0.2× 61 0.6× 30 2.0k
David E. Zembower United States 16 481 1.1× 195 0.5× 645 1.7× 8 0.1× 65 0.7× 26 1.1k
Antonella Peduto Italy 19 341 0.8× 137 0.3× 290 0.8× 8 0.1× 67 0.7× 29 869
Mladen Mintas Croatia 21 903 2.1× 40 0.1× 394 1.0× 69 0.5× 123 1.2× 86 1.4k
Tai Shun Lin United States 15 420 1.0× 69 0.2× 441 1.2× 13 0.1× 395 4.0× 24 887
Chung‐Kyu Ryu South Korea 23 900 2.1× 410 1.0× 390 1.0× 14 0.1× 48 0.5× 67 1.3k
Vithal M. Kulkarni India 21 700 1.6× 76 0.2× 646 1.7× 9 0.1× 178 1.8× 77 1.4k

Countries citing papers authored by Norbert Dereu

Since Specialization
Citations

This map shows the geographic impact of Norbert Dereu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Dereu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Dereu more than expected).

Fields of papers citing papers by Norbert Dereu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Dereu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Dereu. The network helps show where Norbert Dereu may publish in the future.

Co-authorship network of co-authors of Norbert Dereu

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Dereu. A scholar is included among the top collaborators of Norbert Dereu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Dereu. Norbert Dereu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evers, Michel, Anne Bousseau, Jean‐Christophe Carry, et al.. (2003). Synthesis of non-immunosuppressive cyclophilin-Binding cyclosporin A derivatives as potential anti-HIV-1 drugs. Bioorganic & Medicinal Chemistry Letters. 13(24). 4415–4419. 13 indexed citations
3.
Poujade, Christèle, Michel Evers, Jean‐Christophe Carry, et al.. (1996). Betulinic Acid Derivatives:  A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry. Journal of Medicinal Chemistry. 39(5). 1069–1083. 106 indexed citations
4.
Evers, Michel, Christèle Poujade, Yves Ribeill, et al.. (1996). Betulinic Acid Derivatives:  A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action. Journal of Medicinal Chemistry. 39(5). 1056–1068. 108 indexed citations
5.
Labaudinière, Richard, et al.. (1992). .omega.-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. Journal of Medicinal Chemistry. 35(23). 4315–4324. 17 indexed citations
6.
Labaudinière, Richard, et al.. (1992). .omega.-[(.omega.-Arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors. Journal of Medicinal Chemistry. 35(17). 3156–3169. 18 indexed citations
7.
Labaudinière, Richard, et al.. (1992). .omega.-[(.omega.-Arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists. Journal of Medicinal Chemistry. 35(17). 3170–3179. 4 indexed citations
8.
Labaudinière, Richard, et al.. (1992). .omega.-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. Journal of Medicinal Chemistry. 35(23). 4306–4314. 18 indexed citations
9.
Lamberts, L., et al.. (1991). Electrochemical behaviour of pharmacologically interesting seleno-organic compounds—2. 7-substituted-N-Aryl-1,2-benzisoselenazol-3(2H)-one. Electrochimica Acta. 36(3-4). 631–637. 14 indexed citations
10.
Scurlock, Rodger D., et al.. (1991). DEACTIVATION OF SINGLET MOLECULAR OXYGEN BY ORGANO‐SELENIUM COMPOUNDS EXHIBITING GLUTATHIONE PEROXIDASE ACTIVITY and BY SULFUR‐CONTAINING HOMOLOGS*. Photochemistry and Photobiology. 54(5). 733–736. 17 indexed citations
11.
Christiaens, Léon, et al.. (1991). Ortholithiation As a Tool for the Synthesis of Ebselen Analogues. Synthetic Communications. 21(1). 85–98. 25 indexed citations
12.
Renson, M. & Norbert Dereu. (1991). [Benzisoselenazolinones and their derivatives, a new series of anti-inflammatories and antioxidants].. PubMed. 45(5). 322–30. 3 indexed citations
13.
Parnham, Michael J., et al.. (1989). Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs). Inflammation Research. 27(3-4). 306–308. 51 indexed citations
14.
Cantineau, R., et al.. (1986). Synthesis of 75Se‐2‐phenyl‐1,2‐benzisoselenazol‐3(2H)‐one (PZ 51; ebselen. A novel biologically active organo‐selenium compound. Journal of Labelled Compounds and Radiopharmaceuticals. 23(1). 59–65. 24 indexed citations
15.
Dereu, Norbert, et al.. (1984). Ebselen. Drugs of the Future. 9(10). 741–741. 14 indexed citations
16.
O'Brien, Daniel H., et al.. (1983). Tellurium-125 and selenium-77 NMR shifts for symmetric and unsymmetric diorganyl chalcogenides. Organometallics. 2(2). 305–307. 42 indexed citations
17.
Dereu, Norbert & M. Renson. (1981). Synthese de la tellurochromone, de tellurochromannones et d'analogues thienocondenses. Journal of Organometallic Chemistry. 208(1). 11–21. 10 indexed citations
18.
Weber, Roland, et al.. (1980). Thienoisothiazoles, thienoisoselenazoles et selenoloisoselenazoles. Bulletin des Sociétés Chimiques Belges. 89(9). 773–778. 4 indexed citations
19.
Dereu, Norbert & M. Renson. (1979). THIOPHENES CONDENSED WITH TELLURIUM HETEROCYCLES. Phosphorous and Sulfur and the Related Elements. 6(1-2). 73–73. 1 indexed citations
20.
Dereu, Norbert, et al.. (1975). Heterocycles tellures:Synthese et proprietes de tellurochromannones‐4. Journal of Heterocyclic Chemistry. 12(2). 423–426. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026